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NIOSH Activities
 Rostering
 Health Hazard Evaluations 
(HHEs)
 Technical Guidance and Communication
 Health Surveillance
 Toxicity Testing
Rostering
 Rostered over 52,000 response 
workers
 Staging areas and training sites
 Paper-based and web-based
 BP employees, contractors, federal and state 
employees, volunteers
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Paper & Electronic Records
As of 10-12-10
Total Collected:  55,533
Percentage
Male 81%
Female 19%
Asian 3%
Hispanic 8%
Black 36%
All Others 53%
Deepwater Horizon Response Worker Rostering
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Health Hazard Evaluations: 
Six Work Categories
On Shore Evaluations: 
 Beach clean-Up
Wildlife rehabilitation 
 Equipment decontamination and waste 
stream management
Off Shore Evaluations:
 Source Control
 In-situ burns
 Booming, skimming, dispersant operations
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Toxicity Testing
 Acute animal testing ongoing with:
 Dispersant (Nalco Corexit 9500A)
 Crude Oil from the source (sample from well head 
obtained May 23rd)
 Dispersant/crude oil mixture
 Inhalation studies
 Measuring pulmonary, cardiovascular, and CNS 
outcomes
 Dermal studies
 Assessing hypersensitivity and immune-mediated 
responses
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